Evidence map›Paper›PMID 27108533›Full record

ArticleScientific reports2016

A CRISPR/Cas9 system adapted for gene editing in marine algae.

Marianne Nymark, Amit Kumar Sharma, Torfinn Sparstad, Atle M Bones, Per Winge

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Special Issue "Microalgal Molecules and Enzymes 2.0".International journal of molecular sciences · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Induction of a neurotoxin in diatoms by iron limitation via cysteine synthase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Review
  14. Progress and challenges in CRISPR/Cas applications in microalgae.Journal of microbiology (Seoul, Korea) · 2025
    Review
  15. Genetic engineering in diatoms: advances and prospects.The Plant journal : for cell and molecular biology · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Comparative RNA-Seq of TenMarine drugs · 2024
    Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marianne NymarkDepartment of Biology, Norwegian University of Science and Technology, N-7491 Trondheim, Norway.
Amit Kumar SharmaDepartment of Biology, Norwegian University of Science and Technology, N-7491 Trondheim, Norway.
Torfinn SparstadDepartment of Biology, Norwegian University of Science and Technology, N-7491 Trondheim, Norway.
Atle M BonesDepartment of Biology, Norwegian University of Science and Technology, N-7491 Trondheim, Norway.
Per WingeDepartment of Biology, Norwegian University of Science and Technology, N-7491 Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we report that the CRISPR/Cas9 technology can be used to efficiently generate stable targeted gene mutations in microalgae, using the marine diatom Phaeodactylum tricornutum as a model species. Our vector design opens for rapid and easy adaption of the construct to the target chosen. To screen for CRISPR/Cas9 mutants we employed high resolution melting based PCR assays, mutants were confirmed by sequencing and further validated by functional analyses.

Indexed as

CRISPR-Cas SystemsAquatic OrganismsDiatomsGene Editing

Identifiers

PMID27108533
PMCPMC4842962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.